Grant Support

Focus Surgery greatly acknowledges the help and support received from the several funding agencies listed on this page to further the research, development, and product activities in the areas of HIFU to accelerate the use of HIFU and HIFU devices in the clinic to treat cancer and other diseases non-invasively.

Grants

New Energy Development Organization (NEDO), MITI, Tokyo, Japan.

NIH 1 R43 CA83244-01: "Quantitative Imaging and Treatment with Focused Ultrasound," (Phase I SBIR).

NIH 1 R43 CA81340-01: "High Intensity Ultrasound for Prostate Treatment," (Phase I SBIR).

NIH 1 R43 DK59664-01: "Ultrasound Imaging and Therapy for Prostate Cancer," (Phase I SBIR).

NIH 1 R43 HL70366-01: "Acoustocautery," (Phase I SBIR).

NIH 2 R44 CA83244-02: "Quantitative Imaging & Treatment with Focused Ultrasound," (Phase II SBIR).

NIH 2 R44 CA81340-02A2: "High Intensity Ultrasound for Prostate Treatment," (Phase II SBIR).

NIH 2 R44 DK059664-02A1: "Ultrasound Imaging and Therapy for Prostate Cancer," (Phase II SBIR).

U.S. Army 054-032-0148: "Robotic High Intensity Focused Ultrasound (HIFU) Manipulator System for Critical Systems for Trauma and Transport (CSTAT)," (Phase I STTR).

Indiana 21st Century Research & Technology Fund, matching funds for: "Robotic High Intensity Focused Ultrasound (HIFU) Manipulator System for Critical Systems for Trauma and Transport (CSTAT)." 

NIH 1 R43 CA121661-01: "HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer," (Phase I SBIR).

 U.S. Army A2-2297: "Robotic High Intensity Focused Ultrasound (HIFU) Manipulator System for Critical Systems for Trauma and Transport (CSTAT)," (Phase II STTR).

The Sonablate^® is an investigational device limited by Federal Law to investigational use in the United States.

Send mail to focus@focus-surgery.com with questions or comments about this web site.
Copyright © 2004-2007